Axsome Therapeutics
AXSM
AXSM
196 hedge funds and large institutions have $1.97B invested in Axsome Therapeutics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 67 increasing their positions, 66 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
196
Holders Change
-22
Holders Change %
-10.09%
% of All Funds
3.14%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.14%
New
21
Increased
67
Reduced
66
Closed
42
Calls
$79.2M
Puts
$56.9M
Net Calls
+$22.4M
Net Calls Change
-$23.8M
Top Buyers
| 1 |
Millennium Management
New York
|
$64.1M |
| 2 |
RI
RTW Investments
New York
|
$233M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$84.2M |
| 4 |
Holocene Advisors
New York
|
$32.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$72.2M |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
$0 |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
$37.4M |
| 3 |
CC
Cannell & Co
New York
|
$7.35M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$12.3M |
| 5 |
Jane Street
New York
|
$1.34M |
